Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from PLTR

Palantir and GE Aerospace Are Working Together on Military Aircraft. Is PLTR or GE Stock a Better Buy Here?

Palantir offers higher‑growth, higher‑volatility upside as an AI defense software pure play, while GE Aerospace provides steadier, cash‑rich exposure to aircraft and engine demand; which is “better” depends on whether you prioritize aggressive capital gains (PLTR) or more predictable compounding with a dividend (GE).

Barchart

Palantir Is Now a Sports Betting Stock. Does That Make PLTR a Buy Here?

Palantir still looks like a richly valued core AI infrastructure name where the sports-betting angle is a nice add-on — worth holding or buying on pullbacks, but not chasing blindly at more than 150 times forward earnings.

Barchart

Wall Street Loves Palantir Stock as the Iran War Rages On

Rosenblatt analysts say Palantir stands to benefit and is likely to receive more federal contracts.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Palantir Stock Forecast: Is PLTR Heading to $260 or Dropping Further From Here?

Rapid adoption of its AIP, strong U.S. commercial growth, expanding government contracts, and improving margins signal sustained growth for Palantir in 2026.

Barchart

Palantir Stock Up 17% in 1 Month as Iran Tensions Ignite Defense AI Boom

War fears push Palantir stock higher. Can PLTR stock keep climbing in 2026?

Barchart

Down Nearly 15% in 2026, Should You Buy the Dip in Palantir Stock?

Barchart

Peter Thiel Is Dumping Palantir Stock. Should You?

Peter Thiel’s plan to sell $280 million worth of shares has raised investor questions, but analysts largely view it as routine liquidity rather than a negative signal.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Palantir Stock Rises on Iran Conflict—But Here’s the Real Story

Palantir stock is rising on geopolitical tensions, but long-term investors should focus on its AI-driven growth which could strengthen commercial demand

MarketBeat

Buying In-the-Money Palantir Calls Looks Attractive Here for Value Buyers

Long-term PLTR investors can afford to buy cheap in-the-money (ITM) PLTR call options six months away by selling short PLTR put options. This article shows one play that looks especially attractive.

Barchart

Palantir Stock Drops 38%. Should You Buy PLTR for 2026 or Stay Away?

Palantir stock has pulled back from its 52-week high. However, the company’s underlying business momentum remains solid in 2026.

Barchart

Palantir Is in a ‘Category of One.’ Why Mizuho Says You Should Buy PLTR Stock Now.

Mizuho upgraded Palantir to “Outperform,” arguing the company is in a “category of one” thanks to its exceptional growth and margin expansion.

Barchart

Palantir Just Opened a New DoD Door—What Changes Now?

Palantir won DISA Impact Level 6 authorization for sensitive DoD cloud workloads. See why it matters, how commercial growth helps, and key chart levels.

MarketBeat

Play the ‘SaaS Apocalypse’ Selloff in Palantir Stock With This 1 Winning, Protective Options Trade

Here’s a winning framework for a married put spread on Palantir.

Barchart

Up 265% in the Past 5 Days, Is There Any More Upside Left for Rackspace Stock?

Rackspace stock has been in a sharp uptrend ever since it announced a strategic partnership with Palantir. But RXT shares remain super risky to own in 2026.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

If Palantir is Near a Bottom, What's the Best Play in PLTR Stock?

Palantir put options have high premiums for out-of-the-money exercise prices, making them attractive to short-sellers. For example, selling short a 7% lower exercise put yields 3.7% over one month and 2.7% with a 11% lower put strike price.

Barchart

Down 24% in 2026, Where Is Palantir Stock Headed Next and Should You Buy PLTR Here?

Palantir stock has been in a freefall this year amid a broader software rout, but Mizuho believes PLTR shares will recover sharply as the year unfolds.

Barchart

Palantir Stock Just Got Cheaper – Will Buying The Recent Dip Pay Off?

Palantir’s valuation remains high, but the recent decline has eased some concerns. Also, analysts’ sentiment toward PLTR stock has improved over the past month.

Barchart

Has Palantir Bottomed? Probably, Based on Huge, Unusual Put Options Activity in PLTR

Palantir stock may have hit a bottom after several tranches of large, unusual volume in out-of-the-money PLTR put options traded today. Palantir's strong free cash flow and FCF margins imply a higher price target.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

The Next 2 Tech Winners Smart Investors Are Eyeing

The smartest money is looking beyond AI headlines.

MarketBeat

Palantir Is Down 27%, But the Long-Term Math Still Favors Bulls

Palantir has captured only a small slice of its massive TAM. Strong margins and AI-driven demand suggest long-term growth despite recent PLTR stock volatility

Barchart

Palantir Just Received DISA Authorization. Does That Make PLTR Stock a Buy, Sell, or Hold?

DISA authorized Palantir's technology for on-premises and edge deployments. The approval lets government customers deploy Palantir's AI anywhere, from data centers to vehicles.

Barchart

As Palantir Bets on 61% Revenue Growth in 2026, Should You Buy Palantir Stock?

PLTR stock is beating estimates again and again, but Wall Street is not convinced. Should you buy the dip?

Barchart

Stop Worrying About the Software Armageddon and Buy These 5 Stocks Now

Wedbush analysts think the selloff for software stocks is overdone.

Barchart

Palantir May Be ‘Truly Iconic.’ Overvalued, High-Risk PLTR Stock Isn’t.

Why my risk management system keeps me from chasing momentum in hot stocks like Palantir.

Barchart

Wall Street Is Cozying Up to Palantir Stock After Q4. Does That Make PLTR a Buy Here?

Wall Street is finally warming to Palantir after a blowout Q4 that delivered 70% revenue growth, 57% adjusted operating margins, and multiple analyst upgrades, but the stock still suffers from valuation concerns.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.